Relationship of ECG findings to phenotypic expression in patients with hypertrophic cardiomyopathy: A cardiac magnetic resonance study

International Journal of Cardiology

Volumn 167, Issue 3, 2013, Pages 1038-1045

  Delcrè, Sara Dalila Luisella ^a   Di Donna, Paolo ^a   Leuzzi, Stefano ^a   Miceli, Salvatore ^a   Bisi, Marta ^b   Scaglione, Marco ^a   Caponi, Domenico ^a   Conte, Maria Rosa ^c   Cecchi, Franco ^d   Olivotto, Iacopo ^d   Gaita, Fiorenzo ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Division of Cardiology   (Italy)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Cardiac magnetic resonance; ECG; Hypertrophic cardiomyopathy; Hypertrophy

Indexed keywords

GADOLINIUM;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; ECG ABNORMALITY; ELECTROCARDIOGRAM; FEMALE; HEART ARRHYTHMIA; HEART BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREDICTIVE VALUE; PREVALENCE; PRIORITY JOURNAL; Q WAVE; QRS COMPLEX; QT PROLONGATION; SCORING SYSTEM; ST SEGMENT DEPRESSION; ST SEGMENT ELEVATION; T WAVE INVERSION;

CARDIAC MAGNETIC RESONANCE; ECG; HYPERTROPHIC CARDIOMYOPATHY; HYPERTROPHY;

ADULT; AGED; CARDIOMYOPATHY, HYPERTROPHIC; COHORT STUDIES; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MIDDLE AGED; PHENOTYPE;

EID: 84880921114     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.03.074     Document Type: Article

References (52)

1. B.J. Maron Hypertophic cardiomyopathy: a systematic review JAMA 287 10 2002 1308 1320
2. B.J. Gersh, B.J. Maron, and R.O. Bonow 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines Circulation 124 24 2011 Dec 13 e783 e831
3. M. Haghjoo, S. Mohammadzadeh, and M. Taherpour ST-segment depression as a risk factor in hypertrophic cardiomyopathy Europace 11 2009 643 649
4. B.J. Maron, W.C. Roberts, H.A. McAllister, D.R. Rosing, and S.E. Epstein Sudden death in young athletes Circulation 62 2 1980 218 229
5. D. Corrado, G. Thiene, A. Nava, L. Rossi, and N. Pennelli Sudden death in young competitive athletes: clinicopathologic correlation in 22 cases Am J Med 89 5 1990 588 596
6. B.J. Maron, J. Shirani, L.C. Poliac, R. Mathenge, W.C. Roberts, and F.O. Mueller Sudden death in young competitive athletes: clinical, demographic, and pathological profiles JAMA 276 3 1996 199 204
7. D. Corrado, C. Basso, M. Schiavon, and G. Thiene Screening for hypertrophic cardiomyopathy in young athletes N Engl J Med 339 6 1998 364 369
8. D. Corrado, A. Pelliccia, and H.H. Bjornstad Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Cardiovascular pre-partecipation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of European Society of Cardiology Eur Heart J 26 5 2005 516 524
9. A. Pelliccia, F.M. Di Paolo, and F.M. Quattrini Outcomes in athletes with marked ECG repolarization abnormalities N Engl J Med 358 2 2008 152 161
10. D.D. Savage, S.F. Seides, and C.E. Clark Electrocardiographic findings in patients with obstructive and nonobstructive hypertrophic cardiomyopathy Circulation 58 3 1978 402 406
11. C.J. McLeod, M.J. Ackerman, R.A. Nishimura, A.J. Tajik, B.J. Gersh, and S.R. Ommen Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram J Am Coll Cardiol 54 3 2009 229 233
12. J.V. Montgomery, K.M. Harris, S.A. Casey, A.G. Zenovich, and B.J. Maron Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy Am J Cardiol 96 2 2005 270 275
13. P. Charron, O. Dubourg, and M. Desnos Diagnostic value of electrocardiography and echocardiography for familial hypertrophic cardiomyopathy in genotyped adult population Circulation 96 1 1997 214 219
14. B.J. Maron, J.K. Wolfson, E. Cirò, and P. Spirito Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy Am J Cardiol 51 1 1983 189 194
15. T. Konno, M. Shimizu, and H. Ino Phenotypic differences between electrocardiographic and echocardiographic determination of hypertrophic cardiomyopathy in genetically affected subjects J Intern Med 258 3 2005 216 224
16. B.J. Maron, J.S. Gottdiener, and S.E. Epstein Patterns and significance of distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy. A wide angle, two dimensional echocardiographic study of 125 patients Am J Cardiol 48 3 1981 418 428
17. L.M. Shapiro, and W.J. McKenna Distribution of left ventricular hypertrophy in hypertrophic cardiomyopathy: a two-dimensional echocardiographic study J Am Coll Cardiol 2 3 1983 437 444
18. M.S. Maron, B.J. Maron, and C. Harrigan Hypertrophic cardiomyopathy phenotype revisited after 50 years with cardiovascular magnetic resonance J Am Coll Cardiol 54 3 2009 220 228
19. J.A. Lima, and M.Y. Desai Cardiovascular magnetic resonance imaging: current and emerging applications J Am Coll Cardiol 44 6 2004 1164 1171
20. J.C. Moon, N.G. Fisher, W.J. McKenna, and D.J. Pennell Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography Heart 90 6 2004 645 649
21. C.E. Rochitte, E.M. Tassi, and A.A. Shiozaki The emerging role of MRI in the diagnosis and management of cardiomyopathies Curr Cardiol Rep 8 1 2006 44 52
22. I. Olivotto, M.S. Maron, and C. Autore Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy J Am Coll Cardiol 52 7 2008 559 566
23. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliot, G.C. Smith, and D.J. Pennel Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 9 2003 1561 1567
24. C. Rickers, N.M. Wilke, and M. Jerosch-Herold Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy Circulation 112 6 2005 855 861
25. T. Papavassiliu, S. Fluchter, and D. Haghi Extent of myocardial hyperenhancement on late gadolinium-enhanced cardiovascular magnetic resonance correlates with Q waves in hypertrophic cardiomyopathy J Cardiovasc Magn Reson 9 3 2007 595 603
26. H. Satoh, F. Matoh, and K. Shiraki Delayed enhancement on cardiac magnetic resonance and clinical, morphological, and electrocardiographical features in hypertrophic cardiomyopathy J Card Fail 15 5 2009 419 427
27. J.M. Wilson, R.P. Villareal, R. Hariharan, A. Massumi, R. Muthupillai, and S.D. Flamm Magnetic resonance imaging of myocardial fibrosis in hypertrophic cardiomyopathy Tex Heart Inst J 29 3 2002 176 180
28. J. Bogaert, M. Goldstein, F. Tannouri, J. Golzarian, and S. Dymarkowski Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging AJR Am J Roentgenol 180 4 2003 981 985
29. K. Teraoka, M. Hirano, and H. Ookubo Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy Magn Reson Imaging 22 2 2004 155 161
30. F. Matoh, H. Satoh, and K. Shiraki Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy J Card Fail 13 5 2007 372 379
31. D.H. Kwon, N.G. Smedira, and E.R. Rodriguez Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia J Am Coll Cardiol 54 3 2009 242 249
32. E.W. Hancock, B.J. Deal, and D.M. Mirvis American Heart Association Electrocardiography and Arrhythmias Committee; Council on Clinical Cardiology; American College of Cardiology Foundation; Heart Rhythm Society. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology J Am Coll Cardiol 53 11 2009 992 1002
33. H.H. Friedman Diagnostic electrocardiography and vectorcardiography 1971 McGraw-Hill New York
34. D.W. Romhilt, and E.H. Estes Jr. A point-score system for the ECG diagnosis of left ventricular hypertrophy Am Heart J 75 6 1968 752 758
35. J.J. Morris Jr., E.H. Estes Jr., R.E. Whalen, H.K. Thompson Jr., and H.D. McIntosh P-wave analysis in valvular heart disease Circulation 29 1964 242 251
36. M. Sokolow, and T.P. Lyon The ventricular complex in left hypertrophy as obtained by unipolar precordial and limb leads Am Heart J 37 2 1949 161 186
37. A.L. Dollar, and W.C. Roberts Usefulness of total 12-lead QRS voltage compared with other criteria for determining left ventricular hypertrophy in hypertrophic cardiomyopathy: analysis of 57 patients studied at necropsy Am J Med 87 4 1989 377 381
38. S. Bongioanni, F. Bianchi, and A. Migliardi Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy Am J Cardiol 100 3 2007 503 506
39. T. Konno, N. Fujino, and K. Hayashi Differences in the diagnostic value of various criteria of negative T wave for hypertrophic cardiomyopathy based on a molecular genetic diagnosis Clin Sci (Lond) 112 11 2007 577 582
40. F. Alfonso, P. Nihovannopoulos, J. Stewart, S. Dickie, R. Lemerv, and W.J. McKenna Clinical significance of giant negative T waves in hypertrophic cardiomyopathy J Am Coll Cardiol 15 5 1990 965 971
41. k Uchiyama, K. Hayashi, and N. Fujino Impact of QT variables on cardiac outcome of genotyped hypertrophic cardiomyopathy Ann Noninvasive Electrocardiol 14 1 2009 65 71
42. B.J. Maron Q wave in hypertrophic cardiomyopathy: a reassessment J Am Coll Cardiol 16 2 1990 375 376
43. R. Lemery, A. Kleinebenne, P. Nihoyannopoulos, V. Aber, F. Alfonso, and W.J. McKenna Q waves in hypertrophic cardiomyopathy in relation to the distribution and severity of right and left ventricular hypertrophy J Am Coll Cardiol 16 2 1990 368 374
44. Y. Koga, A. Yamaga, K. Hiyramuta, H. Ikeda, and H. Toshima Mechanisms of abnormal Q waves in hypertrophic cardiomyopathy assessed by intracoronary electrocardiography J Cardiovasc Electrophysiol 15 12 2004 1402 1408
45. C.A. Dumont, L. Monserrat, and R. Soler Interpretation of electrocardiographic abnormalities in hypertrophic cardiomyopathy with cardiac magnetic resonance Eur Heart J 27 14 2006 1725 1731
46. K. Ujino, M.E. Barnes, and S.S. Cha Two-dimensional echocardiographic methods for assessment of left atrial volume Am J Cardiol 98 9 2006 1185 1188
47. M.D. Cerqueira, N.J. Weissman, and V. Dilsizian American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare profassionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association Circulation 105 4 2002 539 542
48. C.J. Harrigan, D.C. Peters, and C.M. Gibson Hypertrophic cardiomyopathy: quantification of late gadolinium enhancement with contrast-enhanced cardiovascular MR imaging Radiology 258 1 2011 Jan 128 133
49. Christos V. Bourantas, Nikolay P. Nikitin, and Huan P. Loh Prevalence of scarred and dysfunctional myocardium in patients with heart failure of ischemic origin: a cardiovascular magnetic resonance study J Cardiovasc Magn Reson 13 1 2011 53
50. F.I. Marcus, W.J. McKenna, and D. Sherrill Diagnosis of arrhythmogenic right ventricular cardiomyophaty/dysplasia: proposed modification of the Task Force Criteria Eur Heart J 31 7 2010 Apr 806 814
51. M. Malik, K. Hnatkova, V. Batchvaron, Y. Gang, P. Smetana, and A.J. Camm Sample size, power calculation, and their implications for the cost of thorough studies of drug induced QT interval prolongation Pacing Clin Electrophysiol 27 12 2004 1659 1669
52. A.D. Mc Gavigan, E. Clark, F.R. Quinn, A.C. Rankin, and P.W. Macfarlane Localization of accessory pathways in the Wolff-Parkinson-White pattern - physician versus computer interpretation of the same algorithm Pacing Clin Electrophysiol 30 8 2007 998 1002